摩根基金 - 基因治療主題基金 - JPM基因治療主題(美元) - A股(累計)
90.35美元0.46(0.51%)
2024/12/23更新
績效 / 1月3.74%
3月11.56%
1年10.31%
晨星評等-
- 1.現金0.06%
- 2.股票24.37%
- 3.債券0.00%
- 4.其他75.57%
- 1.美國75.57%
- 2.歐洲不包含歐元區8.29%
- 3.日本5.88%
- 4.歐元區4.16%
- 5.大洋洲2.10%
- 1.Vericel Corp3.63%
- 2.Krystal Biotech Inc3.28%
- 3.Novartis AG Registered Shares3.21%
- 4.Gilead Sciences Inc3.19%
- 5.Bio-Techne Corp3.16%
- 6.Vertex Pharmaceuticals Inc3.14%
- 7.Alnylam Pharmaceuticals Inc3.12%
- 8.PTC Therapeutics Inc3.09%
- 9.Sarepta Therapeutics Inc3.05%
- 10.Arcellx Inc2.98%
- 1.現金0.06%
- 2.股票24.37%
- 3.債券0.00%
- 4.其他75.57%
- 1.美國75.57%
- 2.歐洲不包含歐元區8.29%
- 3.日本5.88%
- 4.歐元區4.16%
- 5.大洋洲2.10%
- 1.Vericel Corp3.63%
- 2.Krystal Biotech Inc3.28%
- 3.Novartis AG Registered Shares3.21%
- 4.Gilead Sciences Inc3.19%
- 5.Bio-Techne Corp3.16%
- 6.Vertex Pharmaceuticals Inc3.14%
- 7.Alnylam Pharmaceuticals Inc3.12%
- 8.PTC Therapeutics Inc3.09%
- 9.Sarepta Therapeutics Inc3.05%
- 10.Arcellx Inc2.98%